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Abstract.  During the purification of laminin-proteo- 
glycan complexes from rat RN22 Schwannoma cell- 
conditioned medium,  a  laminin-rich  fraction was ob- 
tained which lacked neurite-promoting activity. Since 
laminin  from several sources is known to have potent 
neurite-promoting  activity, this result suggested that ei- 
ther this laminin  was inactive or its activity was some- 
how masked by associated molecule(s).  The latter pos- 
sibility was supported by the demonstration that the 
inactive laminin-containing  fraction inhibited active 
laminin-containing  fractions.  This inhibitory  activity was 
partially purified by using ion exchange chromatogra- 
phy and isopycnic centrifugation.  The purified material 
contained proteoglycan based on its high affinity for 
cationic resin,  high buoyant density, large heterodis- 
perse appearance on electrophoretic gels, ability to la- 
bel with inorganic  sulfate, sensitivity to trypsin and 
glycosaminoglycan lyases, and heat stability. 
A quantitative  in vitro bioassay was used to monitor 
the inhibitor after treatments aimed at defining its ac- 
tivity.  The isolated Schwarmoma-derived inhibitor (a) 
inhibits the neurite-promoting activity of purified rat, 
mouse, and human laminin;  (b) is active whether 
presented to laminin  in solution or after either the in- 
hibitor or laminin  is first bound to the culture substra- 
tum;  (c) does not act by displacing laminin  from the 
substratum;  (d) can be prevented from binding to 
neurite-promoting  laminin  substrates by polyclonal and 
monoclonal anti-laminin  or polyclonal anti-entactin 
antibodies; and (e) is abolished by proteases or glycos- 
aminoglycan lyases but not by heat.  The above results 
suggest that the neurite-promoting activity of laminin 
is subject to regulation through association with a pro- 
teoglycan and entactin. 
C 
OMPONENTS of the  basal  lamina  promote  neuritic 
outgrowth from several types of embryonic neurons 
in vitro (Baron yon Evercooren et al.,  1982; Davis 
et al., 1985a; Edgar et al., 1984; Lander et al., 1982, 1985; 
Manthorpe et al.,  1983;  Rogers et al.,  1983).  Several  ex- 
tracellular  matrix  macromolecules  including  fibronectin 
(Akers et al.,  1981), laminin  (Baron yon Evercooren et al., 
1982; Davis et al.,  1985a),  collagens  type I and IV (Car- 
bonetto et al.,  1983),  and  a  heparan  sulfate  proteoglycan 
(Hantez-Ambroise  et al.,  1987) have been reported to pos- 
sess neurite-promoting  activity.  In vitro,  cells release into 
their culture media neurite-promoting  factors  that  express 
their activity when bound to polycationic substrata  (Collins, 
1978; Davis et al.,  1985a).  Of these,  laminin appears to be 
the most potent factor and it is often found complexed with 
other extracellular  matrix constituents  such as proteoglycans 
and entactin/nidogen (Carlin et al., 1981; Davis et al., 1985a; 
Dziadek et al.,  1986; Lander et al.,  1985; Paulsson et al., 
1987).  These associated molecules affect the behavior of 
laminin  during  purification  and may alter its character and 
interaction with extracellular  matrix and cell surface compo- 
nents. Also, preparations of laminin have been described that 
have different molecular compositions, immunological  prop- 
erties, heparin  binding  properties, and proteoglycan affini- 
ties (Davis et al., 1985a,b, Edgar et al., 1988; Lander et al., 
1983, 1985; Sakashita  et al.,  1980). 
The significance of laminin's association with entactin and 
proteoglycans  remains unclear.  In one report epidermal cell 
attachment  to laminin was significantly improved due to en- 
tactin  in a  laminin-entactin  matrix  (Alstadt  et al.,  1987). 
Proteoglycans and their component glycosaminoglycan chains 
have generally not been found to promote neurite outgrowth, 
and may even inhibit outgrowth on other substrates  (Akeson 
and Warren,  1986). Also, inhibition of cell attachment to ex- 
tracellular matrix proteins by extracellular  proteoglycans has 
been demonstrated  (see Ruoslahti,  1988). 
Analysis of conditioned medium from rat RN22 Schwan- 
noma cells showed that  low buoyant density proteoglycans 
and entactin copurified with laminin  neurite-promoting  ac- 
tivity (Davis et al., 1987). Laminin has been shown to be es- 
sential for the neurite-promoting  activity of these complexes 
(Davis  et al.,  1985a;  Lander et al.,  1985).  In the present 
study we found that in vitro some Schwannoma cell laminin 
was released in a complexed form that did not express any 
neurite-promoting  activity.  From these complexes  we have 
isolated a material  which inhibits the neurite-promoting  ac- 
tivity  of purified  laminin.  Pretreating  neurite-promoting 
laminin-entactin  substrates  with anti-laminin or anti-entac- 
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inhibitory  material  has high bouyant density and contains 
heparan/chondroitin  sulfate proteoglycan and its inhibitory 
activity is sensitive to glycosaminoglycan lyases. 
Materials and Methods 
Isolation off'S-labeled Schwannoma Neurite- 
promoting and Inhibitory Activities 
Growth conditions for the rat RN22 Schwannoma cells and the methods for 
labeling with 35SO4 have been described (Davis et al.,  1987).  8 liters of 
RN22 conditioned medium containing 80 ml 35S-labeled  RN22 medium 
was first applied to a  100-ml  bed volume DEAE (DE52; Whatman, Inc., 
Clifton, NJ) ion-exchange column (2.5-cm-diam) and eluted with a 600-ml 
linear salt gradient from 0.15-0.6 M NaCl in 10 mM phosphate buffer, pH 
8.0. Laminin immunoreactivity began to elute at 0.3 M NaCI in the gradient 
and overlapped with the elution of radiosulfntr,,d material (see Results). 
Fractions eluted between 300 and 420 ml of the gradient were pooled and 
diluted to 0.15 M NaCI with phosphate buffer (10 mM, pH 8.0). This diluted 
pool was applied to a 10-ml bed volume DEAE column and bound material 
was eluted using a  60-ml NaCI gradient (0.15--0.6 M). The laminin im- 
munoreactivity which eluted at 0.2-0.3 M NaCI was collected and pooled 
(POOL I). Also, the inhibitory activity (see below) began to elute at 0.3 M 
NaCI and was also collected and pooled (POOL II). Pool II was concen- 
trated by ultrafiltration using an XM100 membrane (Amicon Corp., Dan- 
vers, MA) and dialyzed against 0.4 M guanidine-HCl in 50 mM Tris-HCI, 
pH 7.5. Solid CsC1 was added to give density of 1.35 g/ml and samples were 
subjected to isopycnic centrifugation at 180,000 g  for 48 h.  High density 
fractions (>1.5 g/ml) were pooled (Pool A) and dialyzed against PBS, pH 7.2. 
Laminin antigen was measured by an ELISA (Engvall, 1980) performed in 
polystyrene, 96-well plates using polyclonal and monoclonal antibodies as 
previously described (Davis et al.,  1985a).  Fractions were assayed for 
neurite-promoting activity using 8-d ciliary ganglion neurons (Manthorpe 
et al., 1981, 1983). Radioactivity was monitored by liquid scintillation. Pro- 
tein was measured by the method of Lowry et al. (1951) using BSA as a stan- 
dard.  Glycosaminoglycan content was measured by Alcian blue binding 
using heparan and chondroitin sulfates (Sigma Chemical Co., St.  Louis, 
MO) as standards according to Bartold and Page (1985). 
To address whether proteoglycan is involved in the inhibitory activity, we 
cultured the RN22 cells in the presence of an inhibitor of proteoglycan as- 
sembly, 4-methyl umbelliferyl-/3-D-xyloside. Conditioned medium  from 
RN22 cultures grown in the presence of 1 mM/3-~-xyloside was collected, 
heat-treated, and assayed for activity. 
Gel Electrophoresis, Immunoblotting, and 
Autoradiography 
SDS-PAGE (4-12%) was run under reducing conditions using the buffer 
conditions of Laemmli (1970).  Unstained gels were electroblotted to nitro- 
cellulose sheets by the method of Towbin et al. (1979)  and the blots were 
immunostained for laminin as described by Davis et al. (1985a)  or stained 
by colloidal gold using Aurodye (Janssen Life Science Products, Piscataway, 
NJ). Autoradiograpby was performed on the immunobiots by exposing them 
to XAR-5 x-ray film (Eastman Kodak Co., Rochester, NY) for 5 d at -70°C. 
Enzyme Digestion 
Some test samples were treated with proteoglycan lyases or proteolytic en- 
zyme before assay for activity or analysis by SDS-PAGE. For analysis of 
proteoglycans, samples were incubated for 3 h at 37°C with heparitinase 
(heparin lyas¢ I[; Sigma Chemical Co.) at 1 U/ml in 50 mM Tris-HCI, pH 
7.5, containing 25 mM sodium acetate and 5 mM calcium acetate and/or 
chondroitinase ABC (Miles Laboratories, Inc,, Naperville, IL) at 0.2 U/ml, 
under the same conditions except that calcium acetate was excluded. Diges- 
tions were terminated by boiling. Protease digestion was performed using 
100 #g/rnl trypsin (Irvine Scientific, Santa Ana, CA) in PBS, followed by 
the addition of 200/~g/ml trypsin inhibitor (Sigma Chemical Co.). 
Induction and Inhibition of Neurite Outgrowth 
Neurite promotion and inhibition were assayed as substratum-bound activi- 
ties on polyornithine-coated tissue culture wells (Manthorpe et al.,  1983). 
For neurite promotion assays, polyornithine wells were treated for 2 h with 
purified rat yolk sac laminin purified according to Engvall et al. (1983) or 
rat RN22 Schwannoma cell conditioned medium fractions in PBS (50 t~l) 
and then washed with sterile PBS. Embryonic day 8 chick ciliary ganglion 
neurons were seeded 003 neurons per well) in serum-free NI medium (Bot- 
tenstein and Sato, 1979) containing 1% albumin and ciliary neuronotrophic 
factor (40 trophic units/ml) (Barbin et al., 1984) and incubated in 5% CO2 
in humidified air. Neurite outgrowth was scored by pbase-contrast micros- 
copy after 4  h  by counting the percentage of neurons bearing processes 
greater than four cell body diameters. When serial dilutions of purified rat 
laminin were presented to polyornithine-coa~xl tissue culture  wells and 
ciliary neurons cultured on the resulting substratum, the maximal neurite 
outgrowth occurred when "°25 ng laminin antigen was applied (i.e., 500 
ng/ml x  50 ~l/well). Over 95 % of the laminin antigen had adsorbed to the 
polyornithine-coated wells (determined by ELISA of the unadsorbed solu- 
tion, data not shown). 
Neurite-inhibitory activity was assayed by mixing rat laminin and sam- 
ples to be tested for inhibitory activity (50 #1 total volume) and incubating 
the mixture in polyoruithine wells for 2  h,  followed by three substrate 
washes with sterile PBS. In some experiments samples were added as fol- 
lows: (a) laminin was first bound to polyornithine wells for 2 h followed by 
washing (the wells were blocked with 1% serum albumin solution in some 
cases) and then inhibitory sample was added; (b) the inhibitory sample was 
first incubated in polyornithine wells for 2 h followed by washes and addi- 
tion of laminin; (c) the inhibitory sample and laminin were preincubated for 
1 h in polypropylene tubes before being applied to and incubated in polyor- 
nithine wells for 2 h. Ciliary test neurons were seeded, cultured, and scored 
as described above. We define the half maximal inhibition as 1 neurite in- 
hibitory unit (NIU) I and the titer in NIU/ml as that dilution of test sample 
(total volume =  50 td) added to the well during substratum treatment elicit- 
ing  1 N1U. 
Results 
Fractionation of RN22-derived Neurite-promoting and 
Inhibitory Activities 
Fractionation of RN22-conditioned medium on DEAE cel- 
lulose is shown in Fig. 1. Over 95 % of the recovered protein 
eluted as one early peak before 0.25 M NaCI while two peaks 
of laminin antigen elnted with '~,0.3 and 0.4 M salt. The first 
and second laminin peaks represented  about one-third and 
two-thirds, respectively, of the total recovered laminin anti- 
gen measured by an ELISA using rabbit polyclonal anti-rat 
laminin antiserum. Over 95 % of the recovered radioactivity 
eluted in one peak immediately after, and overlapping with, 
a second laminin peak. Essentially these same elution pro- 
files were obtained using the previous smaller scale fraction- 
ation (Davis et al.,  1987). 
The previous study (Davis et al., 1987) indicated that the 
overlapping laminin and 3~SO4 peaks from the DEAE cohmm 
contained laminin-proteoglycan complexes possessing neu- 
rite-promoting activity.  In an attempt to resolve free laminin, 
free proteoglycan, and laminin-proteoglycan complexes, the 
overlapping laminin and 35SO4 fractions were pooled as in- 
dicated in Fig. 1, diluted and fractionated on a second, smaller 
DEAE column (Fig. 2). The radioactivity  eluted in a slightly 
broader and earlier peak with 0.3-0.5 M NaCI (Fig. 2 A) as 
compared with the first column (cf. Fig, 1). The laminin anti- 
gen (measured by ELISA using polyclonal anti-rat laminin) 
eluted  as  two  broad  and  slightly  overlapping  peaks  with 
~0.2-0.3 M and 0.3-0.4 M NaCI and these peaks contained 
about one- and two-thirds, respectively, of the recovered an- 
tigen.  Thus, the single laminin-3~SO4 pool from the first col- 
umn resolved in the second column into two laminin peaks, 
1. Abbreviations  used in  this paper:  NIU, neurite inhibitory unit;  NPU, 
neurite-promoting unit. 
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Figure I.  DEAE ion-exchange chromatography of 35SO4-1abeled 
RN22 Schwarmoma  conditioned medium. 8 liters of unlabeled plus 
80 ml of 35S-labeled conditioned media were applied to a 100-ml 
DEAE column from which bound material was eluted by a 600-ml 
0.15-0.6 M-linear NaC1 gradient (represented by a line connecting 
the onset and completion of the elution). Fractions (60 x  10 ml) 
were assayed for total protein (n), radioactivity (n), and laminin 
immunoactivity in an ELISA using polyclonal rat laminin antise- 
rum (e). The late-running peak of laminin immunoactivity (frac- 
tions 30-42,  indicated by bar) which overlapped with the 35SO4 
peak was collected and pooled for further fractionation. 
one of which was associated with nearly all the recovered 
35S-radioactivity. The elution of two laminin peaks from the 
second DEAE column occurred with a little less salt concen- 
tration as that of the laminin from the first column. This re- 
sult suggests that the laminin-35SO4 peak from the first col- 
umn contained laminin-proteoglycan  complexes from which 
the laminin component can be released with additional frac- 
tionation. 
When these same fractions from the second DEAE column 
were examined for laminin antigen using the mouse mono- 
clonal antibody, termed 2E8, the majority of immunoactivity 
was found in one peak which eluted before the peak of radio- 
activity. In fractions containing most of the 35S-radiosulfated 
material, laminin antigen could only be detected by the poly- 
clonal antibodies. Since the 2E8 antibody is known to bind 
to an epitope located in the cross region of laminin on the 
200-kD B subunit (Engvall et al.,  1986),  these results sug- 
gest that in the radioactive peak fractions the 2E8 epitope of 
the laminin B chain is either missing or masked. However, 
2E8 immunoactivity was demonstrated on western blots of 
the same column fractions (Fig. 2 B) showing that the 2E8 
epitope was present in fractions containing the peak of 35S- 
radioactivity but apparently was prevented from interacting 
with the 2E8 antibody in the ELISA. 
Autoradiography on the immunoblots revealed two bands 
of 35S-radioactivity, neither of which comigrated with lami- 
nin polypeptides (Fig. 2 C). One radioactive band was broad, 
diffuse, and in a region corresponding to a relative molecular 
mass of 300-900 kD and is likely to contain radiosulfated 
proteoglycan. The other band was focussed at 150 kD and 
comigrated with the sulfated, laminin-binding protein, en- 
tactin (Paulsson et al.,  1987).  Immunoblots of these same 
DEAE fractions using anti-entactin antibodies showed stain- 
ing of this 150-kD  radiosulfated band, thus supporting its 
identification as entactin (data not shown). 
Each fraction of the second DEAE column was examined 
and scored as containing (+) or not containing (-) neurite- 
promoting activity using the CGs test neurons. The results 
are depicted in Fig. 2 D. At the concentration tested (20/zl 
of sample plus 30 #1 buffer per well) all fractions expressed 
neurite-promoting activity except in those associated with 
the peak of 3~S-radioactivity. Thus, the lack of neurite-pro- 
moting activity correlated with the presence of proteoglycan 
and entactin and the absence of monoclonal antibody 2E8 
binding. However, significant amounts of  laminin antigen are 
detected by immunoblotting in these same peak radioactive 
fractions (cf. Fig. 2), suggesting that the neurite-promoting 
activity, like the 2E8 epitope, was masked by material within 
the peak  35S-radiolabeled  fractions,  e.g.,  by proteoglycan 
and/or entactin. 
Inhibition of  Laminin Neurite-promoting Activity 
Next, we explored more directly whether the peak of 35S- 
radioactivity in POOL II contained a material that could in- 
hibit the neurite-promoting activity of the laminin in POOL 
I. Pools I and II were tested for neurite-promoting activity 
separately and after combination. Results are shown in Fig. 
3. When POOL II was combined with the neurite-promoting 
POOL I, this activity was no longer detected (Fig.  3  C). 
Thus, POOL II contains an activity capable of eliminating 
the neurite-promoting activity in POOL I. Purified mouse, 
rat, and human laminin, all previously shown to possess po- 
tent neurite-promoting activity (Engvall et al.,  1986;  Man- 
thorpe et al., 1983; Wewer et al., 1983),  were similarly in- 
hibited by POOL II (data not shown). 
To monitor and characterize the inhibitor in more detail, 
we used a quantitative bioassay as described in Materials and 
Methods. When serial dilutions of POOL II were incubated 
in wells treated with 500 ng/ml  x  50 td/well (25  ng/well) 
of laminin, a concentration-dependent inhibition of the lami- 
nin activity was observed. The results are shown in Fig. 3 D. 
Characterization of the Schwannoma-derived 
Neurite Inhibitor 
The inhibitory material eluted relatively late from the DEAE 
column (Fig. 2) and was associated with 35SO4-1abeled ma- 
terial, suggesting that it may contain proteoglycan. To isolate 
this component, POOL II was submitted to fractionation by 
isopycnic centrifugation on a CsCI gradient. The CsCI den- 
sity gradient fractions were examined for radioactivity, lam- 
inin  immunoreactivity, neurite-promoting,  and  inhibitory 
activities. The results are shown in Fig. 4. Most of the radio- 
sulfated material had a high buoyant density (>1.5 g/ml) al- 
though a small proportion of radioactivity appeared at a lower 
density (1.35 g/ml). The high density fractions lacked lami- 
nin immunoreactivity (using polyclonal antibodies in ELISA) 
and contained inhibitory activity (Pool A). Laminin antigen 
was present as a distinct peak (1.35 g/ml) which contained 
neurite-promoting activity (Pool B). Apparently the high ionic 
strength of this gradient (0.4  M  guanidine-HCl and 8  M 
CsCI) effectively separated neurite-promoting activity from 
inhibitory activity. Thus, when POOL II samples containing 
laminin but no neurite-promoting activity were subjected to 
isopycnic centrifugation, neurite-promoting activity was re- 
covered. 
The neurite-promoting and inhibitory activities of frac- 
tions obtained during various fractionation steps are shown 
in Table I. The inhibitory activity recovered in the high den- 
Muir et al. Inhibitor  of Laminin  Biological  Activity  2355 Figure 2. Further fractionation of the laminin and 3SS-labeled DEAE fraction by a second DEAE ion-exchange step. Fractions 30-42 from 
lhe first DEAE step (see Fig. 1) were diluted to 0.15 M NaCI and applied to a 6-ml DEAE column from which bound material was eluted 
in l-nil fractions by a 60-ml 0.15-0.6 M linear NaCI gradient (represented by a line connecting the onset and completion of the elution). 
(A) Fractions were assayed for radioactivity  (~) and laminin immunoactivity in an ELISA using a poly¢lonal  antiserum (e) and mottoclonal 
antibody No. 2E8 (A), Bars indicate POOL I (fractions 4-12) and POOL II (fractions 20-32). (B) Western blots from reducing SDS gel 
profiles of every fifth fraction (20 #l) were immunostainexl  for laminin with monoclonal No. 2E8,  Arrow indicates a relative molecular 
The Journal of Cell Biology,  Volume 109, 1989  2356 Figure 3. Bioassay of substratum-bound  neurite-promoting  and neurite-inhibiting  activities derived from Schwannoma-conditioned  medium. 
Purified embryonic day 8 ciliary ganglion neurons were cultured according to Material  and Methods on polyornithine-coated tissue culture 
wells pretreated  with samples from DEAE ion-exchange (A) POOL I, (B) POOL II, and (C) POOL I and POOL II combined, each diluted 
1:10 in a volume of 50/zl. Phase-contrast photomicrographs were taken after 4 h in culture.  (D) A maximal neurite-promoting response 
by CGs neurons was achieved  by incubating the polyornithine-wells  with 50 #l of 500 ng/ml (25 rig/well) of purified  rat laminin ([]).  A 
titration  curve for the inhibitory activity of POOL II sample (o) indicates a titer of 65 NIU/ml. CGs neurons were seeded and maintained 
for 4 h before assessing the percentage  of cells bearing neurites  greater than four cell diameters.  Assays counting 50-100 neurons per well 
were performed in duplicate  and the data points represent  the mean from four experiments.  Standard deviations  were <5 %. Bars,  50 #m. 
sity CsCI fractions (POOL A) represented approximately four 
times (i.e.,  3,800 vs.  1,000 NIUs loaded) the activity found 
in the native second DEAE POOL II starting material,  ap- 
parently because laminin (with its neurite-promoting activ- 
ity)  was separated  away from the  higher density  inhibitor. 
This result indicates that the interaction between laminin and 
inhibitor  is reversible. 
Given that laminin is heat sensitive (Ott et al.,  1982) while 
proteoglycans are often heat stable,  we attempted to destroy 
selectively the laminin activity by heat treatment and thereby 
possibly release inhibitor from laminin-inhibitor complexes. 
The results are shown in Table I. Heat treatment (90°C,  15 
min) of  conditioned medium from RN22 cells and of the lami- 
nin-radiosulfated pool from the first DEAE step resulted in 
mass of 200 kD. (C) The western  blot shown in B was exposed to x-ray film for 3 d and developed.  The arrows indicate  molecular mass 
markers: rat yolk sac larninin  (400 and 200 kD) and entactin  (150 kD). (D) An aliquot  (20 #1) of each of the fractions from the second 
DEAE column elution was examined  for neurite-promoting activity using ciliary ganglion test  neurons and scored as containing (+) or 
not containing (-) such activity. 
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Figure 4. Isopycnic  centrifugation  of  the neurite inhibitor. For buoy- 
ant density analysis, POOL II (from the DEAE fractionation step 
shown in Fig. 3) was made 0.4 M in guanidine-HCl, adjusted to 
1.35 g/ml with crystalline CsCI, and then centrifuged. Gradient 
fractions were assayed for 3sS-radioactivity  (n), laminin immuno- 
activity in an ELISA  using polyclonal antibodies (o), and for the 
presence of neurite-promoting activity (POOL B), and inhibitory 
activity (POOL A) (top horizontal bars). 
the entire loss of neurite-promoting activity and the appear- 
ance of inhibitory activity. Heat treatment of POOL I sam- 
pies  from the  second  DEAE  step  eliminated its  neurite- 
promoting activity but generated no inhibitory activity in ac- 
cordance with the view that this material contains laminin 
but no inhibitor. When Pool II samples were heated, the titer 
of the inhibitory activity increased approximately fourfold. 
Thus, exposure of POOL II to heat (to inactivate laminin 
neurite-promoting activity) increased its inhibitory activity 
to about the same extent as does the isopycnic centrifugation 
(which separated inhibitor from laminin neurite-promoting 
activity). The specific activity of the inhibitor from the CsC1 
gradient pool (Fig. 4) was ',,17,000 inhibitory units/mg pro- 
tein, representing a 90,000-fold increase over the serum-con- 
taining conditioned medium starting material (after heating). 
The inhibitory fractions from the CsCI gradient were pooled 
(POOL A) and analyzed by SDS-PAGE and electroblotting. 
The results are shown in Fig. 5. Sensitive protein staining re- 
vealed a major band with an apparent molecular mass of 150 
kD and a few minor bands (lane I). The 150-kD band reacted 
with anti-entactin antibodies but no laminin immunoreac- 
tivity was detected (results not shown). Autoradiography of 
the radiosulfate labeled material showed a broad band, that 
was most dense in a region corresponding to a relative mo- 
lecular mass of 300--400 kD, and a narrow 150-kD band (lane 
Table L Neurite-promoting and Inhibiting Activity Levels 
at Various Fractionation Steps or after Heat Treatment 
Native  Heat-treated 
Fraction  NPU  NIU  NPU  NIU 
RN22  medium  64,000  0  0  13,800 
First DEAE Pool (Fig.  1)  33,000  0  0  11,000 
Second DEAE Pool I 
(Fig.  2)  5,000  0  0  0 
Second DEAE POOL II 
(Fig.  2)  0  1,000  0  4,100 
CsCI Pool A  (Fig.  4)  0  3,800  0  4,000 
CsCI Pool B  (Fig.  4)  1,400  0  0  0 
Figure 5. SDS-PAGE of CsCI 
inhibitory  fraction (POOL A). 
(Lane 1  ) Aurodye  protein  stain- 
ing of the  inhibitory mater- 
ial electrophoresed on 4-12% 
acrylamide gels under reduc- 
ing conditions and then trans- 
ferred to nitrocellulose. The 
inhibitory material was exam- 
ined by autoradiography  before 
(lane 2) and al~r digestion  with 
heparitinase (lane 3) or chon- 
droitinase ABC (lane 4). The 
arrows indicate  molecular  mass 
markers: rat yolk sac laminin 
(400 and 200 kD) and entactin 
(150 kD) and phosphorylase b 
(97 kD). 
2). The electrophoretic mobility of the high molecular weight 
substance was increased after digestion by heparitinase (lane 
3) and by chondroitinase ABC (lane 4).  Lyases that digest 
different glycoaminoglycans  had no effect (not shown). These 
results indicated that the components in the inhibitory CsC1 
sample are heparan/chondroitin sulfate proteoglycan and en- 
tactin. 
Characterization of the Inhibitory Activity 
The above fractionation studies suggested that the inhibitory 
activity may involve proteoglycan and entactin. To analyze 
further the properties of the inhibitory activity, we submitted 
the CsC1 preparation to several treatments followed by bioas- 
say. The results are shown in Table II. The inhibitor appears 
to be heat stable but trypsin sensitive suggesting that protein 
is important in expression of the inhibitory activity. The abil- 
ity of heparitinase or chondroitinase ABC to eliminate the 
inhibitory activity suggests the involvement of both heparan 
and chondroitin sulfate glycosaminoglycans  in the inhibitory 
activity. The products of lyase digestion (i.e., glycosamino- 
glycan fragments plus core protein) were not active. Also, 
purified heparin, heparan sulfate, chondroitin sulfate (up to 
Table II. Effects of  Selected Treatments on the 
Inhibitory Activity 
Percent of remaining 
Treatment  inhibitory  activity* 
None  100  +  2 
Heat:  95°C,  15  min  100  +  2 
Trypsin  0  +  2 
Chondroitinase ABC  5  5:5 
Heparitinase  10  +  5 
Inhibitory sample of CsCI preparation  (POOL A, Fig. 4) was treated with heat 
or  with  either  trypsin  (100  /~g/ml),  chondroitinase ABC  (0.2  U/ml),  or 
heparitinase  (1 U/mi) for 3 h at 37°C. Inhibitory  titer (ef.  Fig. 3) was deter- 
mined after treatments. Data are averages of quadruplicate  assays in three 
separate  experiments, presented +  SD of the means. 
* Starting  activity  =  160 NIU/ml. 
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Figure  6.  laminin  neurite- 
i  !  i  1 
2  3 
Substrata 
Inhibition  of  substratum-bound 
promoting activity and recovery of activity after inactivation of in- 
hibitor with heparitinase. (1) Polyornithine wells were coated with 
laminin (50 ng/well) which resulted in maximal neuritic outgrowth 
by ciliary test neurons. (2) Treatment of the laminin substratum 
with beparitinase (heparin lyase II) did not alter the activity of  lami- 
nin. (3) The neurite-promoting activity of laminin was inhibited by 
subsequent treatment with the Schwannoma-derived inhibitor (16 
NIU/well). (4) The neurite-promoting activity of laminin was re- 
covered when the inhibited laminin substratum was treated with 
heparitinase (0.1 U/well for 2 h) before initiating the neurite out- 
growth assay. The percentage of test neurons (CGs) bearing neu- 
rites was determined as previously described.  Data represent the 
mean of quadruplicate assays from two separate experiments. 
20 #g/ml), or the chondroitin sulfate proteoglycan decorin, 
which inhibits cell attachment to fibronectin (Brennan et al., 
1983), did not decrease the percentage of neurons bearing 
neurites in response to a laminin substratum. 
To address further whether proteoglycan is involved in the 
inhibitory activity, conditioned medium from RN22 cultures 
grown in the presence of methyl-umbelliferyl B-D-xyloside 
was collected, heat treated, and assayed for activity. Com- 
pared to heat-treated medium from control cultures, medium 
from/~-o-xyloside-treated  cultures (having the same number 
of cells) contained <20% of the inhibitory activity (1.7 and 
0.3 NIU/ml, respectively), suggesting that this activity in- 
volved an intact proteoglyean. Although we were unable to 
assay directly the expression of proteoglycan core protein, 
assays of  these conditioned media for glycosaminoglycan  con- 
tent suggested that xyloside treatment did not alter the synthe- 
sis (or release) of this major proteoglycan component. 
Several experiments were undertaken to test whether the 
inhibitory activity in our assays was due to displacement of 
laminin from the polyornithine-coated substratum.  In one 
experiment, an inhibited substratum, created by adding the 
inhibitor to a defined amount of laminin,  was treated with 
heparitinase  and the treated substratum  then seeded with 
CG8 neurons to test for neurite-promoting activity. The results 
are shown in Fig. 6.  The enzyme treatment eliminated the 
inhibitory activity and restored the neurite-promoting activ- 
ity of laminin. This shows that the inhibitor does not displace 
laminin from the substratum but binds to and blocks the 
substratum-bound laminin. In addition, when a completely 
inhibited substratum (4 neurite-promoting units [NPU]/well 
of laminin plus 8 NIU/well inhibitor) was then treated with 
a high amount of laminin (16 NPU/well), a neurite-promoting 
substratum was created (64%  +  14 neurons bearing neu- 
rites). These results suggest that the inhibitor can be satu- 
rated with additional laminin and that the presence of inhibi- 
tor is not toxic to neurons. 
The inactivation of substratum-bound laminin can be local- 
ized and will persist for many days in vitro. When a laminin- 
substratum was treated with localized inhibitor, neurons seed- 
ed onto the inhibited area did not extend neurites within 24 h 
and exhibited nominal, if any, neurite outgrowth even after 
5 d (Fig. 7). Neurons that had attached adjacent and immedi- 
ately proximal to the inhibited area of the laminin-substratum 
showed extensive outgrowth of neurites which, however, gen- 
erally did not enter the inhibited region. 
To test whether a particular sequence of substratum addi- 
tions was critical for inhibitory activity, dilutions of the inhib- 
tor were presented to wells before addition of the laminin, 
simultaneously with the laminin, or after preincubation with 
laminin in tubes. The results are shown in Fig. 8. The inhibi- 
tor retained its inhibitory effects regardless of the presenta- 
tion sequence. However, the inhibitor exhibited the greatest 
potency (i.e., had the highest titer) when allowed to bind to 
the  substratum  before the  addition  of laminin  and  when 
preincubated with the laminin in solution before addition to 
the polycationic substratum. 
Antibodies Bound to Laminin Protect Its 
Neurite-promoting Activity from Inhibition 
The inhibitory pool from the CsC1 centrifugation (POOL A, 
Fig. 4) was shown to be free of laminin but yet retained the 
capacity to interact with laminin and inactivate its neurite- 
promoting activity. To define further the nature of  this associ- 
ation, we examined whether antibodies which bind to lami- 
nin would prevent its inactivation by the inhibitor. This ap- 
proach used purified RN22 laminin and antibodies that bind 
to laminin but do not block its neurite-promoting activity. 
The results are shown in Table HI. When RN22 laminin was 
preincubated with polyclonal antibodies raised against rat 
yolk sac tumor laminin, which do not block RN22 laminin 
activity,  its  neurite-promoting activity was  minimally de- 
creased by the inhibitor. Similarly, pretreatment of the RN22 
laminin with 2E8 anti-human laminin monoclonal antibody 
also prevented inhibition. Since the 2E8 epitope on laminin 
is located at the cross-region of the laminin molecule (Eng- 
vall et al.,  1986), this region of laminin might participate in 
the interaction between the inhibitor and laminin resulting in 
inhibition. 
The partially purified inhibitor contains  relatively high 
levels of the laminin-binding protein, entactin, which copur- 
ified with the inhibitory proteoglycan even under conditions 
which separated inhibitory activity from laminin neurite-pro- 
moting activity (i.e., isopycnic centrifugation). Like the 2E8 
antibody, entactin is known to bind to laminin near the cross- 
region of laminin (Paulsson et al., 1987). Thus, we examined 
whether  anti-entactin  antibodies  could  interfere with  the 
ability of the inhibitor to interact with laminin. The results 
are presented in Table III. Entactin antibodies, which do not 
by themselves interfere with the neurite-promoting activity 
of RN22 laminin (a preparation containing entactin), did pre- 
vent the inhibition from occurring. 
In  related  experiments,  anti-entactin  antibodies  were 
shown to be immunoreactive with the inhibitory material as 
well as with various tested laminin preparations. To further 
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ized and persistent. The substratum was prepared by 
treating  a  polyornithine-coated tissue  culture  dish 
with RN22 laminin (500 ng/ml). A narrow strip of in- 
hibitor (CsCI POOL A,  1:100) (arrows) was applied 
by allowing the inhibitor solution to be drawn across 
the substratum by capillary action under a fine glass 
fiber. All incubations were performed in water satu- 
rated  air  to  prevent  drying.  The  substratum was 
washed and CGs neurons were seeded uniformly and 
cultured in NI medium containing albumin and ciliary 
neuronotrophic  factor. Phase-contrast  photomicro- 
graph was taken after seven days. Bar, 50 #m. 
examine the role of entactin in the inhibitory activity, the 
isolated inhibitory fraction (CsCI Pool A, Fig. 4) was frac- 
tionated by isopycnic centrifugation run under dissociating 
conditions (in the presence of 2 M guanidine-HCl). A high 
buoyant density fraction containing heparan/chondroitin sul- 
fate proteoglycan, but no entactin, was obtained that con- 
tained •60%  of  the original inhibitory activity. However, the 
laminin preparation used in these assays contained entactin 
immunoreactivity. All preparations of laminin tested con- 
tained substantial entactin immunoreactivity and conditions 
required to dissociate entactin from laminin (see Paulsson et 
al.,  1987) compromised the neurite-promoting activity of 
isolated laminin. Further study using carefully characterized 
preparations of laminin and entactin and neurite-promoting 
laminin fragments which do not associate with entactin will 
be required to assess whether entactin is required for the in- 
hibitory activity. 
Discussion 
Here we report a first characterization of a material that can 
bind to laminin and interfere with its ability to promote neu- 
rite outgrowth from cultured neurons. This material has been 
isolated from medium conditioned by RN22 Schwannoma 
cells by ion-exchange chromatography followed by isopycnic 
centrifugation. The inhibitory material contains proteogly- 
can  based  upon  its  high  affinity  for cationic  resin,  high 
bouyant density,  large heterodisperse appearance on SDS 
gels, ability to become labeled with inorganic radiosulfate, 
sensitivity to trypsin and certain glycosaminoglycan lyases, 
and heat stability.  The proteoglycan-containing material ob- 
tained from the CsCI density gradient also contained a sub- 
stantial amount of the sulfated, 150-kD laminin-binding pro- 
tein, entactin. The fact that the entactin sediments in the high 
density fraction, which is devoid of laminin,  suggests that 
entactin retains an association with the inhibitory proteogly- 
can-containing material. 
The proteoglycan associated with the inhibitory activity is 
apparently  different  from  another  laminin-binding  pro- 
teoglycan in RN22 medium described by Davis et al. (1987) 
which has  a  lower density, higher molecular weight,  and 
does not inhibit laminin neurite-promoting activity. In ion- 
exchange chromatography, much of  the total RN22-conditioned 
medium  laminin co-eluted with proteoglycans under high 
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Figure 8.  Effect of application sequences on in- 
hibitory titer. Serial dilutions of inhibitor (CsCI, 
POOL A) and 25 ng of laminin were presented to 
polyornithine-coated wells in various sequences. 
Inhibitor was presented (a) after laminin, (b) simul- 
taneously with the  laminin,  (c) preincubated in 
tubes before their  combined presentation to the 
wells, or (d) before addition of laminin. For each 
step the applied samples were allowed to hind the 
polyornithine wells for 2 h at 25°C, the wells were 
washed, the CG8 neurons seeded and after 4 h the 
percentage of neurons with neurites greater than 
four cell body diameters in length was determined. 
50-100  neurons  were  scored per well and  two 
wells were counted per experiment; the data points 
represent the mean from four such experiments. 
Standard deviations were <5 %. 
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on the Neurite-promoting Activity of  RN22 Laminin 
Substratum 
(neurons beating  neurites) 
Antibody treatment  Laminin  Plus inhibitor 
%  % 
None  84  0 
Controls (preimmune anti-NF, 
anti-FN)  75-85  0 
Anti-rat yolk sac laminin  75  74 
Anti-human laminin No. 2E8  83  70 
Anti-entactin  85  76 
RN22  laminin  (25  ng) was incubated  in 6-ram-tiara polyornithine-wells  for 
2 h. The laminin-polyornithine  substratum  was treated  with PBS containing 
1% BSA followed by a 30-min incubation with PBS alone or PBS containing 
1:50 dilutions of the following antibodies: polyclonal anti-human fibronectin 
(FAr), monoclonal anfi-neurofllament (NF), polyclonal anti-rat  laminin, mono- 
elonal anti-rat laminin No.  2E8,  or polyclonal anti-mouse entaetin.  Without 
removing the antibodies,  inhibitor (I  60 NIU/ml; CsCl inhibitory fraction) was 
added for 2 h and then the wells were washed.  CGg neurons (103/well) were 
seeded and the percentage of neurons bearing neurites was determined 4 h later 
by scoring 50-100 neurons per well. Conditions were replicated eight times in 
four separate experiments.  Standard deviations  were <10%. 
salt from DEAE and was active in promoting neurites (cf. 
Fig. 1). When this laminin-proteoglycan pool was refractio- 
hated on a second DEAE column, only half of the loaded 
laminin antigen eluted with the proteoglycans and a substan- 
tial amount of laminin now eluted with less salt independent 
of proteoglycan (el. Fig. 2). Only the proteoglycan-associated 
laminin lacked neurite-promoting activity. Subsequent anal- 
ysis of this material (POOL II, Fig. 2) indicated the presence 
of an inhibitor of the associated laminin. The inhibitory ac- 
tivity could be destroyed by glycosaminoglycan  lyase, which 
resulted in the reexpression of laminin neurite-promoting ac- 
tivity. Conversely, the laminin could be selectively denatured 
by heat, which apparently caused release of the inhibitor. 
Thus, by fractionation or treatments that selectively destroys 
one activity, neurite-promotion or inhibition can be expressed 
independently. In summary, unfractionated RN22 medium 
contains antagonistic neurite-promoting and inhibiting ac- 
tivities, with neurite-promoting activity dominating. 
Chromatography and enzyme digestions indicate that the 
proteoglycan-associated inhibitor  is  degraded  and  inacti- 
vated by heparitinase or chondroitinase (Fig. 5 and Table II), 
suggesting the involvement of both heparan and chondroitin 
sulfate glycosaminoglycans in the inhibitory activity. The 
inhibitor is heat stable but trypsin sensitive, suggesting an in- 
tact protein to be important in the manifestation  of the inhibi- 
tory activity. Additional evidence for the role of an intact 
proteoglycan in the inhibitory activity was obtained by grow- 
ing RN22 cultures in the presence of 4-methylumbelliferyl-/~- 
o-xyloside, a competitive inhibitor of glycosaminoglycan  ad- 
dition to proteoglycan core protein (Ratner et al., 1985; Gal- 
liganl et al., 1975). Conditioned medium from xyloside treated 
RN22 cells contained only a small fraction of the inhibitory 
activity of that of untreated cells. 
Proteoglycans found  in  culture  conditioned media  are 
thought to be derived  from membrane-associated proteo- 
glycan (Jalkanen et al., 1987) and a membrane fraction from 
RN22  cells  contains a  proteoglycan with properties  very 
similar to inhibitor isolated from the conditioned medium 
(i.e., similar fractionation, appearance by autoradiography, 
and lyase inactivations). The regulation of proteoglycan syn- 
thesis and deposition may dictate whether laminin expresses 
its inherent neurite-promoting activity. The degradation of 
proteoglycan by specific lyases may remove the inhibition 
and restore neurite-promoting activity to a previously sup- 
pressed substratum. Thus, laminin neurite-promoting activ- 
ity may depend as much on a fine tuning of proteoglycan syn- 
thesis and degradation as on laminin production and its cell 
surface or extraceUular deposition. 
Laminin preparations contain variable amounts of entac- 
tin, a sulfated protein that binds to a region near the cross 
region of laminin (Paulsson et al., 1987).  Since entactin it- 
self can bind laminin, but also copurifies with the inhibitor 
even through high ionic strength conditions, entactin may 
have the ability to interact with both laminin and the inhibi- 
tor. Anti-entactin antibodies prevent the inhibitor from block- 
ing laminin neurite-promoting activity, Also, the monoclo- 
nal antibody 2E8 is known to bind to the cross region of rat 
laminin and, without diminishing neurite-promoting activity 
(Davis et al.,  1987; Engvall et al.,  1986),  will protect the 
neurite-promoting activity of laminin. Thus, the ability of 
the inhibitor to interact with laminin may depend on its as- 
sociation with the cross region of the laminin tertiary struc- 
ture, a region different from the postulated neurite-promot- 
ing domain at the end of the 400-kD long arm (Edgar et al., 
1984;  Engvall et al.,  1986).  Through interaction with the 
cross region of  the laminin molecule, the inhibitor may influ- 
ence the distant neurite-promoting site either directly, by ad- 
ditional binding to another portion of the laminin molecule, 
or indirectly, by inducing laminin conformational changes. 
The ability of the 2E8 and anti-entactin antibodies to protect 
the neurite-promoting activity of laminin raises the possibil- 
ity that entactin or other components may mediate the forma- 
tion of laminin complexes which modulate the potential neu- 
rite-promoting activity of laminin in basement membranes. 
Schwannoma cells have been used in this study as a model 
for Schwann cells in vitro.  Recently we have established 
purified populations of rat sciatic nerve Schwann cells and 
have found that their conditioned media also contain activity 
which inhibits neuritic outgrowth in response to laminin. 
The Schwann cell inhibitory activity had properties identical 
to the RN22 inhibitor (unpublished results). Future studies 
will need to address the inhibitors presence and function in 
vivo. 
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